296 related articles for article (PubMed ID: 14528318)
21. Adenovirus serotype 35 vector-mediated transduction into human CD46-transgenic mice.
Sakurai F; Kawabata K; Koizumi N; Inoue N; Okabe M; Yamaguchi T; Hayakawa T; Mizuguchi H
Gene Ther; 2006 Jul; 13(14):1118-26. PubMed ID: 16541121
[TBL] [Abstract][Full Text] [Related]
22. Sequence analysis of the E3 region and fiber gene of human adenovirus genome type 7h.
Kajon AE; Wadell G
Virology; 1996 Jan; 215(2):190-6. PubMed ID: 8560766
[TBL] [Abstract][Full Text] [Related]
23. Common structure of rare replication-deficient E1-positive particles in adenoviral vector batches.
Murakami P; Havenga M; Fawaz F; Vogels R; Marzio G; Pungor E; Files J; Do L; Goudsmit J; McCaman M
J Virol; 2004 Jun; 78(12):6200-8. PubMed ID: 15163713
[TBL] [Abstract][Full Text] [Related]
24. Development of cell lines capable of complementing E1, E4, and protein IX defective adenovirus type 5 mutants.
Krougliak V; Graham FL
Hum Gene Ther; 1995 Dec; 6(12):1575-86. PubMed ID: 8664382
[TBL] [Abstract][Full Text] [Related]
25. Replication of an adenoviral vector controlled by the human telomerase reverse transcriptase promoter causes tumor-selective tumor lysis.
Lanson NA; Friedlander PL; Schwarzenberger P; Kolls JK; Wang G
Cancer Res; 2003 Nov; 63(22):7936-41. PubMed ID: 14633724
[TBL] [Abstract][Full Text] [Related]
26. Sequence and functional analysis of the human adenovirus type 7 E3-gp19K protein from 17 clinical isolates.
Hermiston TW; Hellwig R; Hierholzer JC; Wold WS
Virology; 1993 Dec; 197(2):593-600. PubMed ID: 8249282
[TBL] [Abstract][Full Text] [Related]
27. Multiply deleted [E1, polymerase-, and pTP-] adenovirus vector persists despite deletion of the preterminal protein.
Hodges BL; Serra D; Hu H; Begy CA; Chamberlain JS; Amalfitano A
J Gene Med; 2000; 2(4):250-9. PubMed ID: 10953916
[TBL] [Abstract][Full Text] [Related]
28. [Construction of adenovirus type 7(vaccine strain) vector and expression of beta-galactosidase gene].
Shi C; Wen L; Liu S
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Dec; 12(4):302-5. PubMed ID: 12526338
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of human CD46 by adenovirus serotype 35 vectors.
Sakurai F; Akitomo K; Kawabata K; Hayakawa T; Mizuguchi H
Gene Ther; 2007 Jun; 14(11):912-9. PubMed ID: 17377598
[TBL] [Abstract][Full Text] [Related]
30. Efficient generation of double heterologous promoter controlled oncolytic adenovirus vectors by a single homologous recombination step in Escherichia coli.
Hoffmann D; Wildner O
BMC Biotechnol; 2006 Aug; 6():36. PubMed ID: 16887042
[TBL] [Abstract][Full Text] [Related]
31. [DNA cloning of Ad7 vaccine strain and sequence analysis of its Sma I H fragment].
Zhou J; Qu J; Shi C
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Mar; 12(1):23-5. PubMed ID: 12515165
[TBL] [Abstract][Full Text] [Related]
32. [Sequence analysis of Ad7 vaccine strain 87 mu-97.4 mu fragment].
Zhou J; Qu J; Shi C
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Jun; 12(2):101-4. PubMed ID: 12515181
[TBL] [Abstract][Full Text] [Related]
33. Novel replication-incompetent vector derived from adenovirus type 11 (Ad11) for vaccination and gene therapy: low seroprevalence and non-cross-reactivity with Ad5.
Holterman L; Vogels R; van der Vlugt R; Sieuwerts M; Grimbergen J; Kaspers J; Geelen E; van der Helm E; Lemckert A; Gillissen G; Verhaagh S; Custers J; Zuijdgeest D; Berkhout B; Bakker M; Quax P; Goudsmit J; Havenga M
J Virol; 2004 Dec; 78(23):13207-15. PubMed ID: 15542673
[TBL] [Abstract][Full Text] [Related]
34. New tools for the generation of E1- and/or E3-substituted adenoviral vectors.
Danthinne X; Werth E
Gene Ther; 2000 Jan; 7(1):80-7. PubMed ID: 10680020
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of adenoviral vectors by flow cytometry.
Weaver LS; Kadan MJ
Methods; 2000 Jul; 21(3):297-312. PubMed ID: 10873484
[TBL] [Abstract][Full Text] [Related]
36. Characterization of human adenovirus 35 and derivation of complex vectors.
McVey D; Zuber M; Ettyreddy D; Reiter CD; Brough DE; Nabel GJ; King CR; Gall JG
Virol J; 2010 Oct; 7():276. PubMed ID: 20959004
[TBL] [Abstract][Full Text] [Related]
37. Protease-deleted adenovirus vectors and complementing cell lines: potential applications of single-round replication mutants for vaccination and gene therapy.
Oualikene W; Lamoureux L; Weber JM; Massie B
Hum Gene Ther; 2000 Jun; 11(9):1341-53. PubMed ID: 10890743
[TBL] [Abstract][Full Text] [Related]
38. Gene expression changes induced by a recombinant E1-/E3- adenovirus type 5 vector in human mammary epithelial cells.
Scibetta AG; Copier J; Barrett A; Chaplin T; Taylor-Papadimitriou J
Intervirology; 2005; 48(6):350-61. PubMed ID: 16024939
[TBL] [Abstract][Full Text] [Related]
39. Sequence polymorphism in the E3 7.7K ORF of subspecies B1 human adenoviruses.
Kajon AE; Xu W; Erdman DD
Virus Res; 2005 Jan; 107(1):11-9. PubMed ID: 15567028
[TBL] [Abstract][Full Text] [Related]
40. Concomitant use of Ad5/35 chimeric oncolytic adenovirus with TRAIL gene and taxol produces synergistic cytotoxicity in gastric cancer cells.
Chen L; Chen D; Gong M; Na M; Li L; Wu H; Jiang L; Qian Y; Fang G; Xue X
Cancer Lett; 2009 Nov; 284(2):141-8. PubMed ID: 19447545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
